# Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

> **NCT06789705** · NA · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 24 (estimated)

## Conditions studied

- Central Diabetes Insipidus

## Interventions

- **DRUG:** MDMA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06789705
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-27
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06789705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06789705, "Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06789705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*